Matching geography Reports matching your search in: Join Alert Me now!Receive bi-weekly email alerts on new market research Sign up today!
|
Stem Cell: market research reports
Stem cells are unique in that they are undifferentiated cells that can differentiate to become virtually any type of cell in the body (totipotent). They therefore represent an ongoing source of the specialized cells that make up the tissues and organs. There is great interest in stem cells because they have potential to replace defective or damaged cells resulting from a variety of disorders and injuries, leading to a range of new regenerative therapies. Stem cells also have value as a research tool, as their in vitro study would allow scientists to learn more about the function of various organs and the development of particular diseases; stem cells may also eventually permit drug developers to test emerging therapies on diseased cells.
Cells must meet very specific criteria in order to be termed stem cells. They must: produce copies themselves; proliferate at a rapid rate; and display certain proteins on their surface that indicate a capacity to differentiate into other tissues, such as bone and cartilage. A stem cell line is a group of cells that all descend from a single original stem cell. Symmetric division gives rise to two identical daughter cells both endowed with stem cell properties. Asymmetric division produces only one stem cell and a progenitor cell with limited self-renewal potential.
Stem Cell market research reports and industry analysis
|
|
$1,500.00
|
|
|
$3,500.00
|
|
|
$199.99
|
|
|
$349.99
|
|
|
$199.99
|
|
|
$4,650.00
|
Cancer Stem Cells Drug Pipeline Update 2012
10/16/2012 | published by: BioSeeker Group AB
... the Hedgehog, Notch, and WNT Pathway. These developmental pathways are frequently activated in neoplasms, and particularly in the rare subpopulation of cancer stem cells. There are today 207 companies plus partners developing 254 cancer stem ...
|
more...
|
$2,249.00
|
Biotechnology Market in India
10/1/2012 | published by: Taiyou Research
... costs have boosted the growth of the industry. With the industry not facing much of the brunt from the global economic recession, the Indian biotechnology industry has been gathering investment and is benefitting from the ...
|
more...
|
$600.00
|
Strategies and Technologies for Target Validation
9/28/2012 | published by: Datamonitor
... major cause of clinical-stage attrition. This report analyses the strategic and technological developments in the field. Features and benefits Understand how the differences between phenotypic and target-based approaches to drug discovery influence target validation strategies. ...
|
more...
|
$3,800.00
|
Hematopoietic Stem Cell Transplantation – Pipeline Review, H2 2012
8/31/2012 | published by: Global Markets Direct
... provides information on the therapeutic development for Hematopoietic Stem Cell Transplantation, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Hematopoietic ...
|
more...
|
$2,000.00
|
Translational Regenerative Medicine: Market Prospects 2012-2022
8/31/2012 | published by: Visiongain
... to 2022. There you investigate the most lucrative areas in that research field, industry and market. Discover prospects for tissue-engineered products, stem cell treatments and gene therapy. We pack our study with information and analysis ...
|
more...
|
$2,739.00
|
|
|
$349.99
|
|
|
$199.99
|
Emerging Pharmaceutical Technologies – Stem Cells
8/1/2012 | published by: CBR Pharma Insights, LLC
... largely unproven at present. Even if companies are not interested in joining the first wave of stem cell therapy developers, they need to be monitoring this sector in order to understand future competitive threats. The ...
|
more...
|
$3,900.00
|
The Neurotechnology Industry 2012 Report
8/1/2012 | published by: NeuroInsights, LLC
... comprehensive pipeline and market analysis to help investors, companies and entrepreneurs easily identify opportunities, understand the competitive landscape, determine risks and understand the dynamics of rapidly changing CNS markets. The report includes detailed information on ...
|
more...
|
$4,500.00
|
Complete 2012 U.S. Cord Blood Banking Industry Report
7/25/2012 | published by: BioInformant Worldwide, L.L.C.
... there are 485 worldwide. Cord blood banks now exist in nearly every developed country, as well as several developing nations. That is a 21-fold increase (2,100%) in the companies involved in the industry, over only ...
|
more...
|
$3,995.00
|
Stem Cell Research in India 2012
7/6/2012 | published by: Netscribes (India) Pvt. Ltd.
... as one of the best therapies for the widely prevalent incurable lifestyle diseases. Awareness campaigns and doctors are playing a key role educating people and especially would-be parents about the benefits associated with preserving stem ...
|
more...
|
$795.00
|
Global Markets for Stem Cells
7/1/2012 | published by: BCC Research
... (CAGR) of 11.7% from 2011 to 2016. The American market for stem cell products was $1.3 billion in 2011. This sector is expected to rise at a CAGR of 11.5% and reach nearly $2.3 billion ...
|
more...
|
$5,450.00
|
Human Embryonic Stem Cell (hESC) Research
7/1/2012 | published by: Global Industry Analysts
... provided for the period 2009 through 2018. The report profiles 26 companies including many key and niche players such as Advanced Cell Technology, Inc., BD Biosciences, BioTime, Inc., Cell Cure Neurosciences Ltd., Cellartis AB, GE ...
|
more...
|
$3,450.00
|
|
|
$3,500.00
|
Mesenchymal Stem Cells - Advances & Applications
6/1/2012 | published by: BioInformant Worldwide, L.L.C.
... interest because they represent a population of cells with the potential to treat a wide range of acute and degenerative diseases. MSCs are advantageous over other stem cells types for a variety of reasons: they ...
|
more...
|
$3,995.00
|
|
|
$3,495.00
|
Stem Cell Technologies: World Market Outlook 2012-2022
5/23/2012 | published by: Visiongain
... market and submarket level. You see discussions of work on stem cells in leading countries too - outlooks, challenges, patenting and regulations. You see forecasting of world-level submarkets to 2022, finding potential revenues: Stem cell ...
|
more...
|
$2,739.00
|
Neuroprotective Products: World Market Prospects 2012-2022
5/10/2012 | published by: Visiongain
... projected sales at overall world market, therapeutic submarket and product level to 2022. The protection of nerve tissues is becoming more important. You can assess the potential for drug revenues there, as well as finding ...
|
more...
|
$2,739.00
|
Stem Cell Research
5/1/2012 | published by: Global Industry Analysts
... and Rest of World. The report profiles 87 companies including many key and niche players such as Advanced Cell Technology, Inc., Athersys, Inc., BioE, Inc., Cellartis AB, Cryo-Cell International, Inc., Cytori Therapeutics, Inc., ES Cell ...
|
more...
|
$4,500.00
|
|